13F

Stock

Akebia Therapeutics, Inc.

AKBA · held by 2 managers

Reported value

$3.59M

Holders

2

+0 new · −0 exited

Holders’ est. mark

$530K

Price effect on 1 books still in the name

Largest holder

$3.58M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC984.5K$3.58M$530KAdded$2.99M
Essential Partners LLC537$1.96KHeld

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.